Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
COMBINATION OF ANTI-PD-1 ANTIBODIES AND BISPECIFIC ANTI-CD20/ANTI-CD3 ANTIBODIES TO TREAT CANCER
No-Receipt date
2023-02891 - 12/09/2023
No-Filing date
20230401589 - 12/09/2023
No-Granting date
3113310 - 09/10/2023
No-EPO application date
16826557.7 - 21/12/2016
No-EPO granting date
3394103 - 28/06/2023
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
10/2023 - 13/11/2023
Expiration date
22/12/2036
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US201562270749 P22/12/2015/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 39/00
A61K 39/395
A61K 45/06
A61P 35/00
A61P 35/02
A61P 43/00
C07K 16/28
C07K 16/30
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1526788
REGENERON PHARMACEUTICALS, INC.
777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
3959625
VARGHESE, BINDU
3959626
THURSTON, GAVIN
3959627
LOWY, ISRAEL
3959628
BROWNSTEIN, CARRIE
Representatives
Code
Firstname
Surname
Address
Town
Zip
745
CHRISTINA
KIORTSI
SOLONOS 136
ATHINA (ATTIKIS)
10677
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
2126
CHRISTINA
KIORTSI
SOLONOS 136
ATHINA (ATTIKIS)
10677
GREECE
Owners History
Title Instruments
Payments history
9 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).